Sensorcaine

Bupivacaine Hydrochloride · BUPIVACAINE HYDROCHLORIDE 5 mg/mL · Injection, Solution · Perineural · Henry Schein, Inc.

NDC 00404-9947-50 · 1 VIAL, MULTI-DOSE in 1 BAG / 50 mL in 1 VIAL, MULTI-DOSE · NDA · View full market →

The short version

17 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now — FDA lists the reason as “discontinuation of the manufacture of the drug”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built

Data sources

CMS NADAC (pharmacy acquisition, weekly)
CMS Part B ASP quarterly payment limits
CMS Maximum Fair Prices (IRA negotiated, NDC-level)
Medicare Part D Spending by Drug (data.cms.gov, name-matched)
VA FSS / Big4 federal contract prices (va.gov, twice monthly)
ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
California SB-17 WAC filings (list price, per package)

Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Medicare Part B pays (ASP+6%)$0.0110per billing unit (0.5 MG)HCPCS J0665 · Jul 1, 2026
Part D plans paid (avg)$0.1949per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Medicare Part B (ASP)

Payment limit per 0.5 MG

$0.011

HCPCS J0665 · Jul 1, 2026 quarter · typically ASP + 6%

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.6%chance of a new FDA shortage posting for bupivacaine hydrochloride (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

Part D specialty tier
Costs ≥ $950/fill · avg $16.83 per prescription
Biologic (BLA)
Injectable / infused
Orphan-drug exclusivity
REMS program

Regulatory

Application: NDA018304
TE code: AP
Approval date: Jan 1, 1982
Patents / exclusivity: None on file

Shortage history

In shortage now — Bupivacaine Hydrochloride PRESERVATIVE FREE, Injection, 2.5 mg/1 mL (NDC 72266-263-10)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bupivacaine Hydrochloride, Injection, 0.25%; 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-10)Feb 20, 2018
Discontinuation of the manufacture of the drug
month 103 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bupivacaine Hydrochloride, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bupivacaine Hydrochloride, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1162-02)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 31722-275-32)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 31722-275-34)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-167-10)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-168-30)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-249-50)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-01)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-10)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-25)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32)Feb 20, 2018
Discontinuation of the manufacture of the drug
month 103 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52)Feb 20, 2018
Discontinuation of the manufacture of the drug
month 103 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bupivacaine Hydrochloride, Injection, 225 mg/30 mL (7.5 mg/mL) (NDC 0409-1165-02)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bupivacaine Hydrochloride, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1159-01)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bupivacaine Hydrochloride, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-1163-01)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-32)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-34)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months
In shortage now — Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-169-10)Feb 20, 2018
month 103 — 5× the typical 20-month injectable shortage · model puts 15% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Bupivacaine Hydrochloride (Injection, Solution)

Labeler	Strength	First seen	Last seen
Asclemed USA, Inc.	BUPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 3, 2026
Eugia US LLC	BUPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 3, 2026
Eugia US LLC	BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL	Jul 15, 2026	Sep 3, 2026
Fresenius Kabi USA, LLC	BUPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 3, 2026
Fresenius Kabi USA, LLC	BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL	Jul 15, 2026	Sep 3, 2026
Henry Schein, Inc.	BUPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 3, 2026
Henry Schein, Inc.	BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL	Jul 15, 2026	Sep 3, 2026
Hikma Pharmaceuticals USA Inc.	BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL	Jul 15, 2026	Sep 3, 2026
Hikma Pharmaceuticals USA Inc.	BUPIVACAINE HYDROCHLORIDE 7.5 mg/mL	Jul 15, 2026	Sep 3, 2026
Hikma Pharmaceuticals USA Inc.	BUPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 3, 2026
Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 3, 2026
Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE 7.5 mg/mL	Jul 15, 2026	Sep 3, 2026
Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL	Jul 15, 2026	Sep 3, 2026
NorthStar RxLLC	BUPIVACAINE HYDROCHLORIDE 7.5 mg/mL	Jul 15, 2026	Sep 3, 2026
Onesource Specialty Pharma Limited	BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL	Jul 15, 2026	Sep 3, 2026
Onesource Specialty Pharma Limited	BUPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 3, 2026
Onesource Specialty Pharma Limited	BUPIVACAINE HYDROCHLORIDE 7.5 mg/mL	Jul 15, 2026	Sep 3, 2026
Xellia Pharmaceuticals USA LLC	BUPIVACAINE HYDROCHLORIDE 7.5 mg/mL	Jul 15, 2026	Sep 3, 2026
Xellia Pharmaceuticals USA LLC	BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL	Jul 15, 2026	Sep 3, 2026
A-S Medication Solutions	BUPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 2, 2026
Anthea Pharma Private Limited	BUPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 2, 2026
Anthea Pharma Private Limited	BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL	Jul 15, 2026	Sep 2, 2026
Anthea Pharma Private Limited	BUPIVACAINE HYDROCHLORIDE 7.5 mg/mL	Jul 15, 2026	Sep 2, 2026
Camber Pharmaceuticals, Inc.	BUPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 2, 2026
Camber Pharmaceuticals, Inc.	BUPIVACAINE HYDROCHLORIDE 7.5 mg/mL	Jul 15, 2026	Sep 2, 2026
Camber Pharmaceuticals, Inc.	BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL	Jul 15, 2026	Sep 2, 2026
Cardinal Health 107, LLC	BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL	Jul 15, 2026	Sep 2, 2026
Fosun Pharma USA Inc.	BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL	Jul 15, 2026	Sep 2, 2026
Fosun Pharma USA Inc.	BUPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 2, 2026
Fresenius Kabi USA, LLC	BUPIVACAINE HYDROCHLORIDE 7.5 mg/mL	Jul 15, 2026	Sep 2, 2026
Henry Schein, Inc	BUPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 2, 2026
Henry Schein, Inc	BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL	Jul 15, 2026	Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirst	BUPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 2, 2026
Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE 225 mg/30mL	Jul 15, 2026	Sep 2, 2026
Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE 150 mg/30mL	Jul 15, 2026	Sep 2, 2026
Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE 25 mg/10mL	Jul 15, 2026	Sep 2, 2026
Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE 250 mg/50mL	Jul 15, 2026	Sep 2, 2026
Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE 50 mg/10mL	Jul 15, 2026	Sep 2, 2026
Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE 75 mg/30mL	Jul 15, 2026	Sep 2, 2026
Medical Purchasing Solutions, LLC	BUPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sensorcaine — NDC 00404-9947-50," retrieved September 3, 2026, https://drugdashboards.com/drug/00404994750.

Free to cite with attribution — see how the data is put together.